CPG RADAR LAUNCHES AI-DRIVEN PLATFORM TO UPLEVEL R&D AND EXPEDITE INNOVATION FOR CPG STAKEHOLDERS

New Platform Analyzes Millions of Data Points from Nutrition Products, Ingredients and Clinical Science to Provide Competitive Insights in Real Time

CLEVELAND, Sept. 13, 2024 /PRNewswire/ — CPG Radar, a new AI-powered platform offering scientific analysis and competitive research to enable product innovation and accelerated time to market for CPG stakeholders, has officially launched. CPG Radar’s AI model is trained on one of the largest proprietary CPG product datasets in the world, with product data from over 200,000 products, and clinical trial data from almost 200,000 clinical trials.  CPG Radar’s dataset includes insights on ingredients, pricing, claims, categories, formats, channels, clinical trials and more. CPG Radar helps brands, ingredient companies and other CPG stakeholders optimize their science, business development and innovation insights to succeed in a competitive marketplace.

CPG Radar founders include long-time CPG product innovator Afif Ghannoum and renowned scientist Dr. Mahmoud Ghannoum. Together they have launched and licensed products in over 100,000 stores, published over 600 peer-reviewed papers, and are named inventors on over a dozen patents worldwide.

“We built a platform that we needed: CPG Radar creates an enormous upfront advantage replacing months of research with analysis that’s deeper and quicker than is possible through human research alone,” says Afif Ghannoum. “Whether you’re an ingredient company, a manufacturer or an investor, access to CPG Radar can radically improve the product development process resulting in better, more differentiated products.”

CPG Radar currently works with companies in the dietary supplement, OTC, and food and beverage spaces, with plans to expand soon into beauty and other categories.

For more information, visit www.cpgradar.com.

PRESS CONTACT

Courtney Pae

courtney@stanton-company.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cpg-radar-launches-ai-driven-platform-to-uplevel-rd-and-expedite-innovation-for-cpg-stakeholders-302247334.html

SOURCE CPG Radar

Staff

Recent Posts

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial

Media ReleaseCOPENHAGEN, Denmark; September 15, 2024 Treatment with rinatabart sesutecan (Rina-S) showed encouraging response rate…

2 hours ago

Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis

Trial investigating Cabometyx® (cabozantinib) in combination with atezolizumab demonstrated a positive trend towards improvement for…

2 hours ago

KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions

RIYADH, Saudi Arabia, Sept. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…

2 hours ago

Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging

Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one…

2 hours ago

23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study

23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit in clear-cell renal-cell carcinoma, with one confirmed…

2 hours ago